Drug Topics

MAY 16, 2025

The investigators hope to pursue a human vaccine in order to improve upon the already existing vaccines.

Vaccines 464

Vaccines 464

PharmaVoice

MAY 16, 2025

A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.

235

235

Drug Topics

MAY 16, 2025

Jeff Goad, PharmD, MPH, discusses hepatitis viruses and the current vaccination schedules available for patients to stay protected.

Vaccines 402

Vaccines 402

PhRMA

MAY 16, 2025

Government price setting policies like Most Favored Nation are a bad deal for American patients.

146

146

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MAY 16, 2025

The announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.

247

247

STAT

MAY 16, 2025

The Food and Drug Administration approved on Friday the first blood test for diagnosing Alzheimer’s disease, opening up a quicker way for patients to get detected for the neurological condition and receive treatment. The test, developed by Japan-based Fujirebio Diagnostics, uses a blood sample to detect the presence of plaques in the brain called amyloid that are thought to be linked to Alzheimer’s.

139

139

STAT

MAY 16, 2025

SAN DIEGO — Optum, the health data and care provider division of UnitedHealth Group, is developing a way to calculate how sick Medicare patients are through artificial intelligence, instead of relying solely on diagnosis codes submitted by physicians. Ken Cohen, a physician and Optum’s executive director of translational research, said Thursday at a conference organized by America’s Physician Groups that he was working with the Duke-Margolis Institute for Health Policy on th

106

106

Drug Topics

MAY 16, 2025

Dihydroergotamine (Brekiya) is an acute treatment to help relieve migraine attacks, and it can come in nasal sprays, injections, and intravenous infusions.

FDA 247

FDA 247

STAT

MAY 16, 2025

WASHINGTON — Kevin Hall, a top nutrition scientist who departed from the National Institutes of Health last month, said he’s unlikely to return to the agency, despite NIH director Jay Bhattacharya’s asking him back.  Hall took the federal government’s early retirement offer last month after several incidents where Health and Human Services officials censored his work, as reported earlier by The New York Times.

101

101

pharmaphorum

MAY 16, 2025

In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 16, 2025

Twenty-eight Democratic members of the House of Representatives are backing the Department of Justice’s case that alleges UnitedHealth Group committed widespread Medicare Advantage fraud by not eliminating unnecessary diagnosis codes of its members. The Democrats urged the federal judge overseeing the case to reject a March recommendation from a special master to dismiss the case, and asked the judge in a legal filing to “allow this case to proceed to jury trial in a public courtro

94

94

pharmaphorum

MAY 16, 2025

Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle

83

83

STAT

MAY 16, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. I’ve been re-reading one of my favorite sci-fi series of all time, Martha Wells’ Murderbot, ahead of its TV debut tomorrow. Tell me, dear reader, what are your favorite sci-fi book adaptations?

88

88

Pharmacy Times

MAY 16, 2025

Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.

65

65

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

MAY 16, 2025

LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the biggest players in pharma, only to see that success stall in recent months, is stepping down as CEO, the company said Friday. Jørgensen, who’s worked at Novo for more than 30 years and has been CEO for eight, will continue in the position for a period “to support a smooth transition to new leadership,” the company said.

86

86

Pharmacy Times

MAY 16, 2025

Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.

65

65

STAT

MAY 16, 2025

SAN FRANCISCO — Leading oncologists said this week that artificial intelligence will one day be as integrated into cancer care as it is in smartphones and self-driving cars — and that this is a change we should welcome. Their comments, made at STAT’s Breakthrough Summit West on Wednesday, reflected an optimistic view for how the health care system can use AI across nearly all aspects of cancer care, from matching patients with clinical trials to predicting how they might far

86

86

Pharmacy Times

MAY 16, 2025

Specialty pharmacists enhance CKD management through personalized care, medication adherence strategies, and collaboration with health care providers.

65

65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

MAY 16, 2025

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

76

76

Pharmacy Times

MAY 16, 2025

A new study reveals that heart failure patients with implantable devices are more likely to receive the pneumococcal conjugate vaccine 13, impacting vaccination rates and mortality.

65

65

STAT

MAY 16, 2025

Earlier this week, Lisa Blunt Rochester asked a seemingly simple question of Robert F. Kennedy Jr. during his testimony to the Senate’s Health, Education, Labor, and Pensions Committee: “Who is the acting CDC director?”  Kennedy, the secretary of Health and Human Services, offered the name “Matt Buzzelli,” who he described as “a public health expert.

66

66

Pharmacy Times

MAY 16, 2025

Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.

65

65

Pharmaceutical Technology

MAY 16, 2025

Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.

59

59

Pharmacy Times

MAY 16, 2025

The regimen, which consists of durvalumab and Bacillus Calmette-Guerin, offers new hope to patients with high-risk non-muscle-invasive bladder cancer.

65

65

European Pharmaceutical Review

MAY 16, 2025

Earlier this week, the UK Government published new plans for the reform of its immigration strategy. The policy paper outlined three key aims: grow the UKs domestic workforce, end reliance on overseas labour and boost growth of its domestic economy. 1 Addressing the UK government’s immigration whitepaper Although the proposals in the UK government’s immigration whitepaper could deliver benefit for a range of sectors, the science industry are calling for confidence and clarity from go

52

52

Pharmacy Times

MAY 16, 2025

The new guidelines urge health care professionals to offer local anesthetics and other medications for intrauterine device (IUD) insertions and other gynecologic procedures.

65

65

Pharmaceutical Commerce

MAY 16, 2025

In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.

52

52

Pharmacy Times

MAY 16, 2025

Advocacy fosters professional development, creates better working conditions, and enhances patient care.

65

65

Pharma Marketing Network

MAY 16, 2025

In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.

52

52

Pharmacy Times

MAY 16, 2025

These pharmacists help bridge gaps for patients in difficult situations.

65

65

PharmExec

MAY 16, 2025

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.

52

52

Pharmacy Times

MAY 16, 2025

A panelist discusses how EGFR tyrosine kinase inhibitors (TKIs) commonly cause dermatologic toxicities (including acneiform rash, dry skin, photosensitivity, and paronychia) and diarrhea, which can significantly impact patients quality of life by causing physical discomfort, affecting appearance, and limiting daily activities.

65

65

PharmExec

MAY 16, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52